CLENE NANOMEDICINE

Serial Number 86302980
Registration 4864007
702

Registration Progress

Application Filed
Jun 6, 2014
Under Examination
Jun 30, 2015
Approved for Publication
May 5, 2015
Published for Opposition
May 5, 2015
Registered
Dec 1, 2015

Attorney Assistance

Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2015-12-01)
Due: Dec 01, 2025 145 days

Basic Information

Serial Number
86302980
Registration Number
4864007
Deadline
December 1, 2025
Description
10 Year - Section 8 and 9 Renewal
Filing Date
June 6, 2014
Registration Date
December 1, 2015
Published for Opposition
May 5, 2015
Drawing Code
4

Status Summary

Current Status
Active
Status Code
702
Status Date
May 2, 2022
Registration
Registered
Classes
005

Rights Holder

CLENE NANOMEDICINE, INC.

03
Address
6550 South Millrock Drive
Suite 50
Salt Lake City, UT 84121

Ownership History

CLENE NANOMEDICINE, INC.

Original Applicant
03
Salt Lake City, UT

CLENE NANOMEDICINE, INC.

Owner at Publication
03
Salt Lake City, UT

CLENE NANOMEDICINE, INC.

Original Registrant
03
Salt Lake City, UT

Legal Representation

Attorney
Janet G Ricciuti

USPTO Deadlines

Next Deadline
145 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2015-12-01)
Due Date
December 01, 2025
Grace Period Ends
June 01, 2026

Application History

45 events
Date Code Type Description
Jun 4, 2025 E89R I TEAS SECTION 8 & 9 RECEIVED
Dec 1, 2024 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
May 2, 2022 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
May 2, 2022 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Apr 27, 2022 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 8, 2021 E815 I TEAS SECTION 8 & 15 RECEIVED
Dec 1, 2020 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Dec 1, 2015 R.PR A REGISTERED-PRINCIPAL REGISTER
Oct 24, 2015 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Oct 23, 2015 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sep 24, 2015 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Sep 17, 2015 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 9, 2015 IUAF S USE AMENDMENT FILED
Sep 9, 2015 EISU I TEAS STATEMENT OF USE RECEIVED
Jun 30, 2015 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 5, 2015 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 5, 2015 PUBO A PUBLISHED FOR OPPOSITION
Apr 15, 2015 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 27, 2015 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 25, 2015 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 24, 2015 XAEC I EXAMINER'S AMENDMENT ENTERED
Mar 24, 2015 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 24, 2015 GNEA O EXAMINERS AMENDMENT E-MAILED
Mar 24, 2015 PBMR Z WITHDRAWN FROM PUB - MANAGING ATTORNEY REQUEST
Mar 24, 2015 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN
Mar 24, 2015 CNEA R EXAMINERS AMENDMENT -WRITTEN
Mar 23, 2015 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 23, 2015 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 23, 2015 XAEC I EXAMINER'S AMENDMENT ENTERED
Mar 23, 2015 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 23, 2015 GNEA O EXAMINERS AMENDMENT E-MAILED
Mar 23, 2015 CNEA R EXAMINERS AMENDMENT -WRITTEN
Mar 12, 2015 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 12, 2015 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 12, 2015 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 24, 2014 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 24, 2014 GNRT F NON-FINAL ACTION E-MAILED
Sep 24, 2014 CNRT R NON-FINAL ACTION WRITTEN
Sep 17, 2014 DOCK D ASSIGNED TO EXAMINER
Jul 28, 2014 AMPX O PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Jul 21, 2014 ALIE A ASSIGNED TO LIE
Jul 13, 2014 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED
Jun 19, 2014 MPMK E NOTICE OF PSEUDO MARK E-MAILED
Jun 18, 2014 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 10, 2014 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceuticals for use in prevention and treatment of demyelinating diseases, autoimmune diseases, infectious diseases and cancer
First Use Anywhere: Sep 8, 2015
First Use in Commerce: Sep 8, 2015

Additional Information

Pseudo Mark
CLENE NANO MEDICINE

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"NANOMEDICINE"